Type 2 polyglandular autoimmune disease (Schmidt's syndrome)

C Betterle; M Volpato; A N Greggio; F Presotto

doi:10.1515/jpem.1996.9.s1.113

Type 2 polyglandular autoimmune disease (Schmidt's syndrome)

J Pediatr Endocrinol Metab. 1996 Mar:9 Suppl 1:113-23. doi: 10.1515/jpem.1996.9.s1.113.

Authors

C Betterle¹, M Volpato, A N Greggio, F Presotto

Affiliation

¹ Institute of Semeiotica Medica, Chair of Clinical Immunology and Allergy, University of Padova, Italy.

PMID: 8887161
DOI: 10.1515/jpem.1996.9.s1.113

Abstract

Data on clinical, genetic, and immunological aspects of sixty patients with type 2 polyglandular autoimmune disease (PGAD) are presented. The literature on this is reviewed and discussed.

Publication types

Review

MeSH terms

Addison Disease* / etiology
Addison Disease* / immunology
Addison Disease* / physiopathology
Adolescent
Adult
Age of Onset
Aged
Animals
Autoantibodies / immunology
Autoantigens / immunology
Child
Child, Preschool
Female
Humans
Infant
Male
Middle Aged
Polyendocrinopathies, Autoimmune* / classification
Polyendocrinopathies, Autoimmune* / epidemiology
Polyendocrinopathies, Autoimmune* / immunology
Polyendocrinopathies, Autoimmune* / physiopathology
Prevalence

Substances

Autoantibodies
Autoantigens